Aishah Nasir

Aishah Nasir

Auto-generated profile, based on publicly available information

Aishah Nasir

Biodiscovery Institute University of Nottingham Nottingham NG7 2RD UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
ANAishah Nasir
Aishah Nasir
JTJordan Thorpe
Jordan Thorpe
LBLaurence Burroughs
Laurence Burroughs
Joris MeursJoris Meurs
Joris Meurs
SPSara Pijuan-Galito
Sara Pijuan-Galito
CDChris Denning
Chris Denning
Human pluripotent stem cells (hPSCs) can be expanded and differentiated in vitro into almost any adult tissue cell type, and thus have great potential as a source for cell therapies with biomedical application. In this study, a fully‐defined polymer synthetic substrate is identified for hPSC culture in completely defined, xenogenic (xeno)‐free conditions. This system can overcome the cost, scalability, and reproducibility limitations of current hPSC culture strategies, and facilitate large‐scale production. A high‐throughput, multi‐generational polymer microarray platform approach is used to test over 600 unique polymers and rapidly assess hPSC‐polymer interactions in combination with the fully defined xeno‐free medium, Essential 8 (E8). This study identifies a novel nanoscale phase separated blend of poly(tricyclodecane‐dimethanol diacrylate) and poly(butyl acrylate) (2:1 v/v), which supports long‐term expansion of hPSCs and can be readily coated onto standard cultureware. Analysis of cell‐polymer interface interactions through mass spectrometry and integrin blocking studies provides novel mechanistic insight into the role of the E8 proteins in promoting integrin‐mediated hPSC attachment and maintaining hPSC signaling, including ability to undergo multi‐lineage differentiation. This study therefore identifies a novel substrate for long‐term serial passaging of hPSCs in serum‐free, commercial chemically‐defined E8, which provides a promising and economic hPSC expansion platform for clinical‐scale application.

22 August 2024 in Advanced Intelligent Systems
Verified
Journal Article
Open access
RORobert Owen
Robert Owen
ANAishah Nasir
Aishah Nasir
MAMahetab H. Amer
Mahetab H. Amer
CNChenxue Nie
Chenxue Nie
XXXuan Xue
Xuan Xue
FRFelicity Rose
Felicity Rose
High‐throughput screening (HTS) can be used when ab initio information is unavailable for rational design of new materials, generating data on properties such as chemistry and topography that control cell behavior. Biomaterial screens are typically fabricated as microarrays or “chips,” seeded with the cell type of interest, then phenotyped using immunocytochemistry and high‐content imaging, generating vast quantities of image data. Typically, analysis is only performed on fluorescent cell images as it is relatively simple to automate through intensity thresholding of cellular features. Automated analysis of bright‐field images is rarely performed as it presents an automation challenge as segmentation thresholds that work in all images cannot be defined. This limits the biological insight as cell response cannot be correlated to specifics of the biomaterial feature (e.g., shape, size) as these features are not visible on fluorescence images. Computer Vision aims to digitize tasks humans do by sight, such as identify objects by their shape. Herein, two case studies demonstrate how open‐source approaches, (region‐based convolutional neural network and algorithmic [OpenCV]), can be integrated into cell‐biomaterial HTS analysis to automate bright‐field segmentation across thousands of images, allowing rapid, spatial definition of biomaterial features during cell analysis for the first time.

16 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JTJordan Thorpe
Jordan Thorpe
ANAishah Nasir
Aishah Nasir
LBLaurence Burroughs
Laurence Burroughs
Joris MeursJoris Meurs
Joris Meurs
SPSara Pijuan-Galito
Sara Pijuan-Galito
CDChris Denning
Chris Denning
Human pluripotent stem cells (hPSCs) can be expanded and differentiated in vitro into almost any adult tissue cell type, and thus have great potential as a source for cell therapies with biomedical application. In this study, a fully-defined polymer synthetic substrate is identified for hPSC culture in completely defined, xeno-free conditions. This system can overcome the cost, scalability and reproducibility limitations of current hPSC culture strategies, and facilitate large-scale production. A high-throughput, multi-generational polymer microarray platform approach was used to test over 600 unique polymers and rapidly assess hPSC-polymer interactions in combination with the fully defined xeno-free medium, Essential 8 TM (E8). This study identifies as novel nanoscale phase separated blend of poly(tricyclodecane-dimethanol diacrylate) and poly(butyl acrylate) (2:1 v/v), which supports long-term expansion of hPSCs and can be readily coated onto standard cultureware. Analysis of cell-polymer interface interactions through mass spectrometry and integrin blocking studies provides novel mechanistic insight into the role of the E8 proteins in promoting integrin-mediated hPSC attachment and maintaining hPSC signaling, including ability to undergo multi-lineage differentiation. This study therefore identifies a novel substrate for long-term serial passaging of hPSCs in serum-free, commercial chemically-defined E8, which provides a promising and economic hPSC expansion platform for clinical-scale application.